MBMikhail M. Beregov

Mikhail M. Beregov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mikhail M. Beregov has a total of 60 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    CT-perfusion parameters and reperfusion therapy in acute ischemic stroke: 24-hour NIHSS dynamics in a retrospective cohort.

    by Ilya L. Gubskiy, Mikhail M. Beregov, Nikolai E. Staroverov, Ivan A. Larionov, Kazachkov Yu. Kirill, Andrey P. Stepanchenko, Valentin A. Nechaev, Nataliya A. Marskaya, Nikolai A. Shamalov

    BACKGROUND: Neurological improvement after acute ischemic stroke depends on multiple clinical and imaging factors, including baseline stroke severity, infarct volume, and the success of reperfusion therapy. Despite technically successful recanalization, 30–50% of patients show no meaningful clinical improvement. AIM: To evaluate the impact of CT perfusion parameters, intravenous thrombolysis, and mechanical thrombectomy on 24‑hour neurological status dynamics measured by the NIHSS in patients with acute ischemic stroke due to large vessel occlusion. METHODS: This retrospective single‑center cohort included 52 patients with acute ischemic stroke caused by large vessel occlusion. CT perfusion data were analyzed using the ArchiMed PRO software. Ridge regression was applied to assess the effects of perfusion parameters, reperfusion therapies, and their characteristics on 24‑hour change in NIHSS. RESULTS: The model explained 44% of the variance in NIHSS change. Statistically significant predictors were baseline NIHSS score (p0.05), degree of recanalization on the TICI scale (p0.05; positive effect), and the performance of mechanical thrombectomy (p0.05; negative effect). Non‑significant trends were observed for infarct core volume (negative effect, p0.05), penumbra volume (positive effect, p0.05), and intravenous thrombolysis (positive effect, p0.05). CONCLUSION: Successful recanalization is the leading predictor of short‑term neurological improvement after acute ischemic stroke. CT perfusion parameters show trends consistent with previous literature; however, the limited statistical power of this cohort prevented these associations from reaching formal statistical significance.

  • Open Access

    Validation of a Russian automated CT perfusion processing system for ischemic stroke

    by Ilya L. Gubskiy, Mikhail M. Beregov, Nikolai E. Staroverov, Ivan A. Larionov, Kirill Yu. Kazachkov, Andrey P. Stepanchenko, Valentin A. Nechaev, Nataliya A. Marskaya, Nikolay A. Shamalov, Губский Илья Леонидович

    BACKGROUND: Automated computed tomography (CT) perfusion analysis systems are critical for patient selection for reperfusion therapy in acute ischemic stroke. Systems such as RAPID (iSchemaView/RapidAI, USA) and Olea Sphere (Olea Medical, France) are widely used in clinical practice; however, a validated domestic system for automated CT perfusion processing is lacking in the Russian Federation. Among similar systems that have a registration certificate in the Russian Federation, Vitrea (Canon Medical Systems, USA, Japan) is available in clinical practice. AIM: To validate the Russian system ArchiMed PRO Chronos by comparing it with the Vitrea (Canon Medical Systems, USA, Japan) software for quantitative assessment of ischemic core and critical hypoperfusion area. METHODS: A retrospective study included 52 patients with acute ischemic stroke caused by large vessel occlusion and symptom onset within 24 hours. Correlation between systems was assessed for ischemic core volume and critical hypoperfusion area determination. RESULTS: Strong correlation was found between systems for ischemic core volume (r=0.95) and critical hypoperfusion area (r=0.85). After excluding studies with inadequate segmentation, correlation improved to r=0.98 and r=0.93, respectively. Adequate segmentation was achieved in 84.6% of cases for both systems. No statistically significant differences between systems were detected (p 0.05). CONCLUSION: The ArchiMed PRO Chronos system demonstrated excellent agreement with Vitrea and can be used for quantitative CT perfusion analysis and patient selection for reperfusion therapy.


  • Open Access

    Assessment of biomarkers in biological fluids and neuroimaging changes in patients with Alzheimer’s disease and glaucoma

    by A. N. Bogolepova, E. V. Makhnovich, E. A. Kovalenko, N. A. Osinovskaya, M. M. Beregov, O. V. Lyang

    Оценка биомаркеров в биологических жидкостях и нейровизуализационных изменений у пациентов с болезнью Альцгеймера и глаукомой

  • Open Access

    Nivolumab-containing therapy in patients with newly diagnosed classical Hodgkin lymphoma: own clinical observations and literature review

    by D. D. Ivanova, E. A. Baryakh, M. A. Mingalimov, E. N. Misyurina, D. S. Polyakov, N. A. Savosina, M. M. Beregov, M. A. Donskoy, A. B. Makeshova, T. N. Tolstykh, et al.

    Classical Hodgkin’s lymphoma (cHL) is a lymphoproliferative disease characterized by the presence of Hodgkin anderezovsky–Reed–Sternberg cells and a tumor microenvironment. Currently, much attention is paid to the microenvironment in cLH. A detailed understanding of the interaction between the tumor and its microenvironment opens up prospects for the cHL diagnosis and treatment. Innovative immunotherapeutic agents such as nivolumab make it possible to control and activate the immune response. Despite the high efficiency of standard protocols in young patients, therapy intensification is associated with organ toxicity and the development of secondary malignant neoplasms. At the same time, in elderly patients, the results of generally accepted antitumor treatment protocols should be considered suboptimal. In the last decade, the treatment of refractory cHL has improved significantly due to the use of immune checkpoint inhibitors.Taking into account the above, the priority issue in modern clinical hematology is to improve cHL treatment strategies not only in elderly but also in young patients by maintaining a balance between high efficacy and low toxicity. Moreover, the inclusion of nivolumab in first-line therapy is not only pathogenetically justified and effective, but also safe. The article presents data from clinical observations of the successful nivolumab use in combination with chemotherapy in patients with newly diagnosed cHL.


  • Open Access

    A case report of a mild neurologic deficit with extensive poststroke damage to the subdominant brain hemisphere: analysis of data obtained from magnetic resonance tractography, functional magnetic resonance imaging, and electroencephalography

    by Ivan S. Gumin, Sergey A. Gulyaev, Mikhail M. Beregov, Vladimir G. Lelyuk

    The severity of damage to different brain areas, including the cortex, can vary significantly in the associated neurologic deficit and reduction in the quality of life, often regardless of the lesion volume. The localization of the abnormalities plays a large part. Lesions of the dominant and subdominant hemispheres can differ greatly in both clinical features and effects on the patient’s quality of life. In this case report, a patient admitted for rehabilitation after two ischemic strokes underwent neurological and neuropsychological examination, complex instrumental diagnostics using electroencephalography, magnetic resonance imaging, computed tomography perfusion, magnetic resonance tractography, and functional magnetic resonance imaging. The patient had minimal left-sided hemiparesis, impaired regulation of voluntary activity, mild decrease in neurodynamic indicators, mildly impaired concentration, and a critical view of his condition. Neuroimaging findings demonstrated extensive postinfarction damage to the right subdominant hemisphere of the brain in the middle cerebral artery circulation. A nonconformity between the brain damage volume and the severity of its clinical signs was observed. Based on functional examination data, the dominant hemisphere was determined, and restructuring the functional centers was suggested. This clinical case was compared with similar ones, and their relationship with the data was analyzed. Information that expands the knowledge of the topography of the altered zones involved in motor and speech functions and the ability to perform arithmetic counting was obtained.

  • The relationship between neuropsychological indicators and neuroimaging changes according to MRI morphometry in patients with Alzheimer’s disease and glaucoma

    by A.N. Bogolepova, E.V. Makhnovich, E.A. Kovalenko, N.A. Osinovskaya, M.M. Beregov

    Objective. Study of neuroimaging changes according to MRI morphometry and their comparison with the structure and severity of cognitive impairment (CI) in patients with Alzheimer’s disease (AD) and primary open-angle glaucoma (POAG). Material and methods. The study involved 90 patients who were divided into two equal groups of 45 people and who early had diagnosis of AD (group 1; median age — 71 [66; 77] years) and POAG (group 2; median age — 68 [64; 77] years). 71] years). All patients underwent assessment of their neurological status, neuropsychological testing, structural MRI of the brain, followed by morphometric data processing. For the purpose of comparative assessment of the obtained MRI morphometry indicators, a group of healthy individuals was taken — group 3 (n=10). Results. In patients with AD, severe cognitive impairment (CI) was detected, and in patients with POAG, pre-dementia CI with a similar neurodegenerative nature was identified. According to MRI morphometry, in the group of patients with AD compared with POAG, there was a decrease in the volumes of gray matter of the brain, hippocampus, right thalamus, amygdala, entorhinal cortex, right cingulate gyrus, fusiform gyrus, as well as thicknesses: entorhinal cortex, cingulate gyrus and fusiform gyrus (p<0.05). When comparing volumes according to MRI morphometry with healthy individuals, patients with AD revealed a statistically significant decrease in all studied neuroimaging indicators, and when comparing thicknesses: left entorhinal cortex, fusiform gyrus; while in POAG only a decrease in the volumes of gray matter of the brain, thalamus, and right medial orbitofrontal cortex was noted. Conclusion. POAG can be considered not only as an independent disease, but also as a predictor of the development of AD, therefore, the statistically significant differences we obtained between the AD group and POAG according to MRI morphometry may reflect the dynamics of the neurodegenerative process and depend on the severity of CI. In this connection, MRI morphometry can be considered not only as a method of early diagnosis, but also as an assessment of disease progression. In this case, it is important to determine not only the thicknesses, but also the volumes of brain structures according to MRI morphometry data.

  • Features of the clinical and neuroimaging picture in patients with early-onset Alzheimer’s disease

    by E.A. Kovalenko, E.V. Makhnovich, A.N. Bogolepova, N.A. Osinovskaya, M.M. Beregov

    The most common cause of severe cognitive impairment in adults is Alzheimer’s disease (AD). Depending on the age of onset, AD is divided into early (<65 years) and late (≥65 years) forms. Early-onset AD (EOAD) is significantly less common than later-onset AD (LOAD) and accounts for only about 5—10% of cases. However, its medical and social significance, as a disease leading to loss of ability to work and legal capacity, as well as premature death in patients aged 40-64 years, is extremely high. Patients with EOAD compared with LOAD have a greater number of atypical clinical variants — 25% and 6—12.5%, respectively, which complicates the differential diagnosis of EOAD with other neurodegenerative diseases. However, the typical classical amnestic variant predominates in both EOAD and LOAD. Also, patients with EOAD have peculiarities according to neuroimaging data: when performing MRI of the brain, patients with EOAD often have more pronounced parietal atrophy and less pronounced hippocampal atrophy compared to patients with LOAD. The article pays attention to the features of the clinical and neuroimaging data in patients with EOAD; a case of a patient with EOAD is presented.


  • Open Access

    Sinonasal diffuse large B-cell lymphoma: own clinical observation and literature review

    by M. A. Mingalimov, E. A. Baryakh, O. L. Kochneva, E. N. Misyurina, Yu. Yu. Polyakov, E. I. Zhelnova, K. V. Yatskov, A. B. Makeshova, T. N. Tolstykh, T. S. Chudnova, et al.

    Diffuse large B-cell lymphoma is the most common immunomorphological variant of lymphoma in adults. Extranodal lesions are observed in a third of patients at the disease onset. The organs most often involved are the gastrointestinal tract, testicles, bones, thyroid gland, and skin. Primary involvement of the nasal cavity and paranasal sinuses occur extremely rarely and cause diagnostic and therapeutic difficulties.The article demonstrates a rare clinical case of newly diagnosed diffuse large B-cell lymphoma with sinonasal tract involvement. It took 6 months to verify the final diagnosis. At the moment, the induction stage of treatment for diffuse large B-cell lymphoma continues, the achieved complete metabolic response is maintained.

  • Features of neuropsychological status and results of magnetic resonance morphometry in patients with Alzheimer’s disease and glaucoma

    by A.N. Bogolepova, E.V. Makhnovich, E.A. Kovalenko, N.A. Osinovskaya, M.M. Beregov

    ЦЕЛЬ ИССЛЕДОВАНИЯ Выявление связи нейропсихологических изменений у пациентов с болезнью Альцгеймера (БА) и первичной открытоугольной глаукомой (ПОУГ), а также оценка результатов МРТ-морфометрии у пациентов с данными заболеваниями. МАТЕРИАЛ И МЕТОДЫ Обследованы 32 пациента (медиана возраста 67 [61,25; 76,75] лет, женщин 78,1%) с БА и ПОУГ. Пациенты были разделены на две группы: 1-я группа — пациенты с БА (n=16); 2-я группа — пациенты с ПОУГ (n=16). У всех пациентов проведен сбор жалоб и анамнеза, оценивались неврологический и нейропсихологический статус, выполнена МРТ головного мозга с последующей морфометрией. РЕЗУЛЬТАТЫ У пациентов обеих групп были выявлены когнитивные нарушения (КН). Тяжесть КН у пациентов с БА была более выраженной по сравнению с пациентами с ПОУГ (ppp<0,05). ЗАКЛЮЧЕНИЕ При БА И ПОУГ отмечается схожесть нейропсихологического профиля, что является отражением нейродегенеративного процесса, характерного для этих заболеваний. При МРТ-морфометрии необходима оценка как объема, так и толщины структур головного мозга. У пациентов с ПОУГ был выявлен нейровизуализационный паттерн, который может быть расценен как показатель глаукоматозного процесса.

  • Modern possibilities of early diagnosis of Alzheimer’s disease in patients with primary open-angle glaucoma

    by A.N. Bogolepova, E.V. Makhnovich, E.A. Kovalenko, N.A. Osinovskaya, M.M. Beregov, A.N. Zhuravleva

    The article presents data on biomarkers for the early diagnosis of Alzheimer’s disease (AD). Particular attention is paid to potential neuroimaging and ophthalmological markers, such methods of early diagnosis of AD as MRI with post-processing data processing and assessment of the volume of brain structures and cortical thickness — MRI morphometry, as well as optical coherence tomography are described. The article shows the relationship between AD and primary open-angle glaucoma and considers a case of AD in a patient with primary open-angle glaucoma.